ESR1 and cancer: Comparison between these screens revealed that along with an expected overlap of some “dropouts”, the two compounds substantially differ in their genetic signatures, which underscores that SRC-3, despite being a key component of the ERα signaling pathway35–39, has a variety of other crucial biological roles in cancer cells.